The study includes a survey of 120 healthcare professionals in the U.S. and Europe and numerous in-depth interviews with healthcare industry experts. Highlighted below are five findings from the study.
1. More than two-thirds (68 percent) of survey respondents say personalized medicine is having a measurable effect on patient outcomes.
2. Roughly the same number of experts predict it will have an impact on their organization in the next two years.
3. Although early results are promising, the majority of organizations are still learning to share data and working on preparations for regulatory.
4. Healthcare organizations continue to make substantial investments in big data and analytics, as well as specialized and basic IT capabilities that will be essential to the success of precision medicine.
5. Many organizations have yet to fully develop business models for personalized medicine, but the financial case for the medical approach is maturing and experts continue to voice optimism related to the profitability of precision medicine.
To access the full report, click here.
More articles on precision medicine:
New technology eases adoption of precision medicine initiative
7 genome sequencing, biobank projects in the news
VA’s Million Veteran Program to aid federal Precision Medicine Initiative
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
